FDA Safety Alert: Meitheal Issues Recall

The Food and Drug Administration (FDA) has announced a recall of 1 lot of cisatracurium besylate injection (Meitheal Pharmaceuticals Inc.) due to mislabeling.The decision to recall the product was made after a product complaint revealed that a portion of cartons...

Clearlake-Backed symplr to Acquire Phynd

SANTA MONICA, CA and HOUSTON, TX – January 25, 2021 —(PRNEWSWIRE)— symplr, a leading global healthcare governance, risk management, and compliance (“GRC”) software-as-a-service (“SaaS”) platform, backed by Clearlake Capital Group, L.P. (together with its affiliates,...